LCD L38070: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — CGS
Policy LCD-L38070 · Clinical Laboratory
New LCD to improve billing for myeloid malignancy testing.
Code intelligence
C92.01 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C92.01.
Normal code riskView ICD-10 detail
Signal breakdown
2 shown · 2 total in platform
Risk: Normal
0
Critical
0%
0
High
0%
2
Routine
100%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Routine
LCD L38123: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — Noridian
Policy LCD-L38123 · Oncology
New LCD impacts myeloid malignancies testing billing.
Audit documentation
Building an audit file that includes C92.01?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription